DocSym
β
Searchsearch
Search
(A30.0) Indeterminate leprosy
More details coming soon
622 in individuals diagnosis indeterminate leprosy confirmed
Diagnosis indeterminate leprosy is diagnosed Men are 5.79% more likely than Women
329
Men receive the diagnosis indeterminate leprosy
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
293
Women receive the diagnosis indeterminate leprosy
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease indeterminate leprosy - Men aged 25-29 and Women aged 90-94
In Men diagnosis is most often set at age 25-29
Less common in men the disease occurs at Age 0-24, 30-95+Less common in women the disease occurs at Age 0-89, 95+
In Women diagnosis is most often set at age 90-94
Disease Features indeterminate leprosy
Absence or low individual and public risk
Indeterminate leprosy - what does this mean
Indeterminate leprosy is caused by the bacterium mycobacterium leprae and is characterized by a single skin lesion or a few small lesions that are hypopigmented, indurated, and anesthetic. it is the mildest form of leprosy and is usually self-limiting.
What happens during the disease - indeterminate leprosy
Indeterminate leprosy is an infectious disease caused by the bacterium mycobacterium leprae. it is characterized by the formation of granulomas in the skin and peripheral nerves, leading to the destruction of nerve endings, resulting in sensory loss, peripheral neuropathy, and skin lesions. this can lead to deformities, disfigurement, and disability. the exact pathogenesis of indeterminate leprosy is still unknown, but it is believed to be due to the direct invasion of m. leprae into the skin and peripheral nerves, leading to the formation of granulomas and subsequent damage to the nerves.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination of the skin and mucous membranes
- Microscopic examination of skin scrapings or biopsy specimens
- Serological tests for leprosy
- Culture for Mycobacterium leprae
- Skin biopsy and histopathology
- X-ray of the affected area
- MRI of the affected area
- Ultrasound of the affected area
- CT scan of the affected area
Treatment and Medical Assistance
Main goal of the treatment: To reduce the symptoms of Indeterminate Leprosy and prevent the spread of the disease.
- Administering multi-drug therapy (MDT) to reduce the bacterial load and prevent the spread of the disease.
- Providing physical therapy to treat nerve damage.
- Providing psychological support to patients to help them cope with the stigma associated with the disease.
- Educating patients about proper hygiene to reduce the risk of further infection.
- Monitoring patients regularly for signs of progression of the disease.
- Providing vaccinations to protect against other bacterial infections.
19 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Indeterminate leprosy - Prevention
The prevention of indeterminate leprosy can be achieved through early diagnosis and treatment of individuals with a suspicious skin rash, as well as through early detection and treatment of contacts of those infected. it is also important to practice good hygiene and to avoid contact with individuals with leprosy. vaccination is not currently available for leprosy, but research is ongoing.